直肠腺癌术前短程与长程放疗后患者报告生活质量与功能结局比较
基于前瞻性PRO登记数据,比较局部直肠癌患者接受术前短程放疗(SCRT,25 Gy/5次)与长程放化疗(LCCRT,50-50.4 Gy/25-28次联合氟嘧啶)后EORTC QLQ-CR29评分变化;术前LCCRT组多项功能下降更明显,术后2年内两组长期QoL与功能结局相当。
要点
- 术前期间LCCRT组DSP、总体QLQ-CR29、尿频及排尿困难下降更明显。
- 术后3个月至2年,两组DSP、总体QLQ-CR29及其他子量表无持续差异。
- 低位前切除亚组LCCRT组1年时DSP与总体评分短暂变差,2年时未持续。
核心结论
- 术后2年SCRT与LCCRT的长期生活质量和功能结局相当,支持术前放疗策略的共同决策。
研究设计与样本
- 从2013至2024年前瞻性PRO登记中纳入接受术前SCRT(25 Gy/5次)或LCCRT(50-50.4 Gy/25-28次联合氟嘧啶)的局部直肠癌患者。
- 323例符合条件患者中206例完成基线PRO(LCCRT n=116;SCRT n=90),使用EORTC QLQ-CR29在基线、放疗期间/后及术后约3个月、6个月、1年、2年评估。
- 主要结局为排便与造口问题子量表(DSP)较基线变化,采用线性混合模型校正基线评分及高危疾病特征。
主要发现
- 基线EORTC QLQ-CR29评分可比,但LCCRT组更可能具有高危疾病特征。
- 术前期间LCCRT与DSP、总体EORTC QLQ-CR29、尿频及排尿困难下降更明显相关。
- 术后两组恢复轨迹相似,3个月、6个月、1年、2年时DSP、总体QLQ-CR29或其他子量表评分无持续差异。
- 低位前切除亚组中,LCCRT组1年时DSP与总体EORTC QLQ-CR29短暂变差,但2年时未持续。
关键数值与推荐
- SCRT方案为25 Gy/5次,LCCRT方案为50-50.4 Gy/25-28次联合同步氟嘧啶。
- 主要结局为EORTC QLQ-CR29的DSP子量表较基线变化,次要结局包括总体评分及肠道、泌尿、性功能子量表。
- 术后2年时两组DSP、总体QLQ-CR29及其他子量表评分无持续差异。
临床怎么用
- 对于局部直肠癌术前放疗,SCRT与LCCRT术后2年生活质量和功能结局相当,可用于共同决策。
- 术前期间LCCRT组排便与造口问题、总体QoL、尿频及排尿困难下降更明显,需关注术前症状管理。
- 低位前切除患者接受LCCRT后1年可能出现短暂DSP与总体QoL变差,但2年时未持续。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Short-course radiation therapy (SCRT) and long-course chemoradiation (LCCRT) are established preoperative strategies for rectal cancer with comparable oncologic outcomes, but longitudinal colorectal cancer-specific patient-reported outcome (PRO) data comparing them are limited. We assessed quality of life (QoL) and functional outcomes using the European Organization for Research and Treatment of Cancer colorectal cancer (EORTC QLQ-CR29) in patients treated with SCRT versus LCCRT. METHODS AND MATERIALS: Patients with localized rectal cancer treated with preoperative SCRT (25 Gy/5 fractions) or LCCRT (50-50.4 Gy/25-28 fractions with concurrent fluoropyrimidine) from 2013 to 2024 were identified from a prospective PRO registry. Patients completed the EORTC QLQ-CR29 at baseline, during/after radiation therapy, and postoperatively at ∼3 months, 6 months, 1 year, and 2 years. The primary outcome was change from baseline in the defecation and stoma problems subscale (DSP), and the secondary outcomes included overall EORTC QLQ-CR29 score and selected bowel, urinary, and sexual function subscales. Linear mixed models, adjusted for baseline score and high-risk disease features, were used to compare longitudinal changes. RESULTS: Of 323 eligible patients, 206 patients completed baseline PROs (LCCRT n = 116; SCRT n = 90). Baseline EORTC QLQ-CR29 scores were comparable, although LCCRT patients were more likely to have high-risk disease features. During the preoperative period, LCCRT was associated with greater declines in DSP, overall EORTC QLQ-CR29, urinary frequency, and dysuria. Postoperatively, both cohorts demonstrated similar recovery trajectories. At 3 months, 6 months, 1 year, and 2 years, no sustained differences were observed in DSP, overall QLQ-CR29, or other subscale scores. In the low anterior resection subset, a transient detriment at 1 year in DSP and overall EORTC QLQ-CR29 was seen in the LCCRT cohort, but this did not persist at 2 years. CONCLUSIONS: Two years after surgery, long-term QoL and functional outcomes were comparable between SCRT and LCCRT, supporting shared decision-making regarding preoperative radiation therapy strategies.
引用
- Shah SN, Harmsen WS, Frechette KM, et al. Patient-Reported Quality of Life and Functional Outcomes After Preoperative Short- Versus Long-Course Radiation Therapy for Rectal Adenocarcinoma. Int J Radiat Oncol Biol Phys. 2026. PMID: 42828530. doi:10.1016/j.ijrobp.2026.08.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。